{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T01:19:05Z","timestamp":1775611145970,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T00:00:00Z","timestamp":1647648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8167081181"],"award-info":[{"award-number":["8167081181"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012669","name":"Natural Science Foundation Project of Chongqing","doi-asserted-by":"publisher","award":["cstc2021jcyj-msxmX0269"],"award-info":[{"award-number":["cstc2021jcyj-msxmX0269"]}],"id":[{"id":"10.13039\/501100012669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.vph.2022.106986","type":"journal-article","created":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T12:07:11Z","timestamp":1647691631000},"page":"106986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Berberine inhibits osteogenic differentiation of aortic valve interstitial cells by interfering Smad1\/5\/8 and NF-\u03baB pathways"],"prefix":"10.1016","volume":"144","author":[{"given":"Qin","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhuan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaguang","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaorong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujia","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangqiao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2022.106986_bb0005","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3389\/fphar.2020.00685","article-title":"Calcific aortic valve disease-natural history and future therapeutic strategies.[J]","volume":"11","author":"Brunilda","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.vph.2022.106986_bb0010","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2018.08.020","article-title":"Novel pharmacological targets for calcific aortic valve disease: prevention and treatments","volume":"136","author":"Myasoedova","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"11","key":"10.1016\/j.vph.2022.106986_bb0015","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1161\/ATVBAHA.114.302523","article-title":"Calcific aortic valve disease: a consensus summary from the Alliance of investigators on calcific aortic valve disease","volume":"34","author":"Yutzey","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2022.106986_bb0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.yjmcc.2019.05.016","article-title":"Development of calcific aortic valve disease: do we know enough for new clinical trials?","volume":"132","author":"Kostyunin","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"28","key":"10.1016\/j.vph.2022.106986_bb0025","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1093\/eurheartj\/ehx653","article-title":"Calcific aortic valve stenosis: hard disease in the heart: a biomolecular approach towards diagnosis and treatment","volume":"39","author":"Peeters","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2022.106986_bb0030","article-title":"Pathogenesis and molecular immune mechanism of calcified aortic valve disease. [J]","volume":"8","author":"Weikang","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.vph.2022.106986_bb0035","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fphys.2018.00201","article-title":"Toll-like receptors, inflammation, and calcific aortic valve disease","volume":"9","author":"Garc\u00eda-Rodr\u00edguez","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.vph.2022.106986_bb0040","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.atherosclerosis.2018.08.029","article-title":"Inflammatory and metabolic mechanisms underlying the calcific aortic valve disease","volume":"277","author":"Cho","year":"2018","journal-title":"Atherosclerosis."},{"issue":"9","key":"10.1016\/j.vph.2022.106986_bb0045","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006339","article-title":"Valve interstitial cells: the key to understanding the pathophysiology of heart valve calcification","volume":"6","author":"Rutkovskiy","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"6","key":"10.1016\/j.vph.2022.106986_bb0050","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/19768354.2018.1528175","article-title":"Involvement of inflammatory responses in the early development of calcific aortic valve disease: lessons from statin therapy","volume":"22","author":"Lee","year":"2018","journal-title":"Anim. Cells Syst. (Seoul)."},{"issue":"4","key":"10.1016\/j.vph.2022.106986_bb0055","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.bbrc.2015.02.028","article-title":"Berberine improves endothelial function by inhibiting endoplasmic reticulum stress in the carotid arteries of spontaneously hypertensive rats","volume":"458","author":"Liu","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.vph.2022.106986_bb0060","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.intimp.2016.12.001","article-title":"Comparative effect of berberine and its derivative 8-cetylberberine on attenuating atherosclerosis in ApoE mice.[J]","volume":"43","author":"Min","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.vph.2022.106986_bb0065","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/jdi.12516","article-title":"Berberine activates peroxisome proliferator-activated receptor gamma to increase atherosclerotic plaque stability in Apoe mice with hyperhomocysteinemia.[J]","volume":"7","author":"Hongjun","year":"2016","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.vph.2022.106986_bb0070","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.yjmcc.2020.03.012","article-title":"Potential role of full-length and nonfull-length progranulin in affecting aortic valve calcification","volume":"141","author":"Huang","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"1","key":"10.1016\/j.vph.2022.106986_bb0075","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/cvr\/cvx180","article-title":"LncRNA TUG1 sponges miR-204-5p to promote osteoblast differentiation through upregulating Runx2 in aortic valve calcification","volume":"114","author":"Yu","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"10","key":"10.1016\/j.vph.2022.106986_bb0080","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015610","article-title":"Age, sex, and valve phenotype differences in fibro-calcific remodeling of calcified aortic valve","volume":"9","author":"Voisine","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/j.vph.2022.106986_bb0085","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10753-012-9579-6","article-title":"Inflammation is associated with the remodeling of calcific aortic valve disease","volume":"36","author":"Cot\u00e9","year":"2013","journal-title":"Inflammation."},{"issue":"2","key":"10.1016\/j.vph.2022.106986_bb0090","first-page":"185","article-title":"Pathogenesis of aortic stenosis: not just a matter of wear and tear","volume":"1","author":"Sverdlov","year":"2011","journal-title":"Am. J. Cardiovasc. Dis."},{"issue":"16","key":"10.1016\/j.vph.2022.106986_bb0095","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1161\/CIRCULATIONAHA.110.006767","article-title":"Calcific aortic valve disease: not simply a degenerative process: a review and agenda for research from the National Heart and Lung and Blood Institute aortic stenosis working group. Executive summary: calcific aortic valve disease-2011 update","volume":"124","author":"Rajamannan","year":"2011","journal-title":"Circulation."},{"key":"10.1016\/j.vph.2022.106986_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.660797","article-title":"Dissecting calcific aortic valve disease-the role, etiology, and drivers of valvular fibrosis","volume":"8","author":"B\u00fcttner","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"7","key":"10.1016\/j.vph.2022.106986_bb0105","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.7150\/thno.30787","article-title":"Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics","volume":"9","author":"Feng","year":"2019","journal-title":"Theranostics."},{"key":"10.1016\/j.vph.2022.106986_bb0110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejphar.2014.01.061","article-title":"Berberine improves pressure overload-induced cardiac hypertrophy and dysfunction through enhanced autophagy","volume":"728","author":"Li","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.vph.2022.106986_bb0115","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/HYPERTENSIONAHA.115.06068","article-title":"Smad3 couples Pak1 with the antihypertrophic pathway through the E3 ubiquitin ligase, Fbxo32","volume":"66","author":"Tsui","year":"2015","journal-title":"Hypertension."},{"key":"10.1016\/j.vph.2022.106986_bb0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.intimp.2016.12.001","article-title":"Comparative effect of berberine and its derivative 8-cetylberberine on attenuating atherosclerosis in ApoE\u2212\/\u2212 mice","volume":"43","author":"Feng","year":"2017","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.vph.2022.106986_bb0125","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1210\/en.2012-1114","article-title":"Up-regulating relaxin expression by G-quadruplex interactive ligand to achieve antifibrotic action","volume":"153","author":"Gu","year":"2012","journal-title":"Endocrinology."},{"issue":"6","key":"10.1016\/j.vph.2022.106986_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020969","article-title":"Preferential activation of SMAD1\/5\/8 on the fibrosa endothelium in calcified human aortic valves--association with low BMP antagonists and SMAD6","volume":"6","author":"Ankeny","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vph.2022.106986_bb0135","article-title":"Bone morphogenetic protein receptors: structure, function and targeting by selective small molecule kinase inhibitors.[J]","volume":"138","author":"Gonzalo","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.vph.2022.106986_bb0140","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.4103\/1673-5374.280305","article-title":"Role of activin receptor-like kinase 1 in vascular development and cerebrovascular diseases.[J]","volume":"15","author":"Jun-Mou","year":"2020","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.vph.2022.106986_bb0145","doi-asserted-by":"crossref","first-page":"17482","DOI":"10.1002\/jcp.28370","article-title":"Berberine attenuates hypoxia-induced pulmonary arterial hypertension via bone morphogenetic protein and transforming growth factor-\u03b2 signaling.[J]","volume":"234","author":"Mingxing","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.vph.2022.106986_bb0150","article-title":"Berberine attenuates chronic atrophic gastritis induced by MNNG and its potential mechanism.[J]","volume":"12","author":"Yuling","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.vph.2022.106986_bb0155","first-page":"14896","article-title":"Berberine protects vascular endothelial cells in hypertensive rats","volume":"8","author":"Wang","year":"2015","journal-title":"Int. J. Clin. Exp."},{"key":"10.1016\/j.vph.2022.106986_bb0160","article-title":"Valve endothelial-interstitial interactions drive emergent complex calcific lesion formation in vitro.[J]","volume":"269","author":"Gee Terence","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.vph.2022.106986_bb0165","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.atherosclerosis.2015.07.008","article-title":"Valvular interstitial cells suppress calcification of valvular endothelial cells.[J]","volume":"242","author":"Jesper","year":"2015","journal-title":"Atherosclerosis"}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189122000350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189122000350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:21:36Z","timestamp":1761528096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189122000350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":33,"alternative-id":["S1537189122000350"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2022.106986","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Berberine inhibits osteogenic differentiation of aortic valve interstitial cells by interfering Smad1\/5\/8 and NF-\u03baB pathways","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2022.106986","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106986"}}